JR...I agree...Kaiser will need to be out in force to defend Mitigate against the naysayers, who will surely come on to the scene again, including the Lovaza and Omega 3 fans....It is not the inferior generics, who are Vascepa's largest competitors...It's these other useless drugs, whose main reason for support by patients and Docs is that they are more cheap.(even if ineffective)
JR. MITIGATE is all in house Kaiser data . They have a state of the art EHR system recording everyone ...MD thru to ER to pharmacy etc Everyone in the trial are from Kaiser hospitals in Nth Ca ...I could probably drive past all of them within 12 hrs assuming no traffic . See my note to Laurent ...any comments ? Kiwi
News 
Market Data 
Discover 
AI
